Author

T. Kovacevic-Preradovic

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

The C-MIC II Follow-Up Study: Safety and Efficacy Results 12 months After Deactivation of Cardiac Microcurrent Therapy.

BACKGROUND The C-MIC II trial demonstrated benefits of 6 months of cardiac microcurrent (C-MIC) therapy in patients with non-ischemic heart failure with reduced ejection fraction (HFrEF). The prospective C-MIC II Follow-Up Study evaluates safety and efficacy outcomes post-device deactivation. METHODS Primary safety-r...

J. Rame, D. Kosevic, T. Kovačević-Preradović et al. · European Journal of Heart Fa... · 0 citations

Open access Aug 2026

Differential Rates of Guideline-Directed Medical Therapy Modification in C-MIC and Control Patients: Results from the C-MIC II Trial.

Consistent improvements in LVEF, 6MWD and KCCQ-OSS across SGLT2i subgroups suggest that the observed benefits are independent of background pharmacologic intensification.

Marat Fudim, T. Kovačević-Preradović, D. Kosevic et al. · ESC Heart Failure · 0 citations

Open access Aug 2026

Subclinical systolic left ventricular dysfunction in patients with non-significant coronary artery stenosis detected by coronary computed tomography (CT) angiography.

Higher CAC score in hypertensive patients with mild LAD stenosis and negative stress testing identify those at risk of subclinical LV dysfunction, which was linked to significantly higher CAC score.

E. Begić, Ada Djozic, N. Mlaco-vrazalic et al. · Medicinski glasnik · 0 citations